Farhad Ali

Array ( [id] => 3996036 [patent_doc_number] => 05919899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Human protein with angiogenesis regulative properties' [patent_app_type] => 1 [patent_app_number] => 8/039297 [patent_app_country] => US [patent_app_date] => 1993-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4542 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919899.pdf [firstpage_image] =>[orig_patent_app_number] => 039297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589513 [patent_doc_number] => 05550221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Nucleic acid molecule encoding the amphotropic virus receptor' [patent_app_type] => 1 [patent_app_number] => 8/050684 [patent_app_country] => US [patent_app_date] => 1993-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3367 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550221.pdf [firstpage_image] =>[orig_patent_app_number] => 050684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3482705 [patent_doc_number] => 05405941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-11 [patent_title] => 'MEKK protein, capable of phosphorylating MEK' [patent_app_type] => 1 [patent_app_number] => 8/049254 [patent_app_country] => US [patent_app_date] => 1993-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 8641 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/405/05405941.pdf [firstpage_image] =>[orig_patent_app_number] => 049254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3425950 [patent_doc_number] => 05459242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-17 [patent_title] => 'Purification of intrinsic factor, and removal of R-protein using cobinamide' [patent_app_type] => 1 [patent_app_number] => 8/033705 [patent_app_country] => US [patent_app_date] => 1993-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 7308 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/459/05459242.pdf [firstpage_image] =>[orig_patent_app_number] => 033705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3108359 [patent_doc_number] => 05407915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-18 [patent_title] => 'Human Bikunin variants as proteinase inhibitors, and medicaments containing these' [patent_app_type] => 1 [patent_app_number] => 8/027602 [patent_app_country] => US [patent_app_date] => 1993-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 8743 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/407/05407915.pdf [firstpage_image] =>[orig_patent_app_number] => 027602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786812 [patent_doc_number] => 05780021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Method for treating type 1 diabetes using .alpha.-interferon and/or .beta.- i' [patent_app_type] => 1 [patent_app_number] => 8/026758 [patent_app_country] => US [patent_app_date] => 1993-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8469 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780021.pdf [firstpage_image] =>[orig_patent_app_number] => 026758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3021547 [patent_doc_number] => 05288855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-22 [patent_title] => 'Extracellular form of the human fibroblast growth factor receptor' [patent_app_type] => 1 [patent_app_number] => 7/997133 [patent_app_country] => US [patent_app_date] => 1992-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4513 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/288/05288855.pdf [firstpage_image] =>[orig_patent_app_number] => 997133 [rel_patent_id] =>[rel_patent_doc_number] =>)